Literature DB >> 28009933

Mass spectrometry-driven drug discovery for development of herbal medicine.

Aihua Zhang1, Hui Sun1, Xijun Wang1.   

Abstract

Herbal medicine (HM) has made a major contribution to the drug discovery process with regard to identifying products compounds. Currently, more attention has been focused on drug discovery from natural compounds of HM. Despite the rapid advancement of modern analytical techniques, drug discovery is still a difficult and lengthy process. Fortunately, mass spectrometry (MS) can provide us with useful structural information for drug discovery, has been recognized as a sensitive, rapid, and high-throughput technology for advancing drug discovery from HM in the post-genomic era. It is essential to develop an efficient, high-quality, high-throughput screening method integrated with an MS platform for early screening of candidate drug molecules from natural products. We have developed a new chinmedomics strategy reliant on MS that is capable of capturing the candidate molecules, facilitating their identification of novel chemical structures in the early phase; chinmedomics-guided natural product discovery based on MS may provide an effective tool that addresses challenges in early screening of effective constituents of herbs against disease. This critical review covers the use of MS with related techniques and methodologies for natural product discovery, biomarker identification, and determination of mechanisms of action. It also highlights high-throughput chinmedomics screening methods suitable for lead compound discovery illustrated by recent successes.
© 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  biomarker; chinmedomics; herbal medicine; lead compounds; mass spectrometry; metabolite; natural products

Mesh:

Substances:

Year:  2016        PMID: 28009933     DOI: 10.1002/mas.21529

Source DB:  PubMed          Journal:  Mass Spectrom Rev        ISSN: 0277-7037            Impact factor:   10.946


  36 in total

Review 1.  Recent advances and effective strategies in the discovery and applications of natural products.

Authors:  Jing Xie; Ai-Hua Zhang; Hui Sun; Guang-Li Yan; Xi-Jun Wang
Journal:  RSC Adv       Date:  2018-01-03       Impact factor: 4.036

2.  High-throughput lipidomics reveal mirabilite regulating lipid metabolism as anticancer therapeutics.

Authors:  Hong-Lian Zhang; Ai-Hua Zhang; Xiao-Hang Zhou; Hui Sun; Xiang-Qian Wang; Liu Liang; Xi-Jun Wang
Journal:  RSC Adv       Date:  2018-10-18       Impact factor: 4.036

3.  NOREVA: normalization and evaluation of MS-based metabolomics data.

Authors:  Bo Li; Jing Tang; Qingxia Yang; Shuang Li; Xuejiao Cui; Yinghong Li; Yuzong Chen; Weiwei Xue; Xiaofeng Li; Feng Zhu
Journal:  Nucleic Acids Res       Date:  2017-07-03       Impact factor: 16.971

4.  Screening the active compounds of Phellodendri Amurensis cortex for treating prostate cancer by high-throughput chinmedomics.

Authors:  Xian-Na Li; Aihua Zhang; Meijia Wang; Hui Sun; Zhidong Liu; Shi Qiu; Tianlei Zhang; Xijun Wang
Journal:  Sci Rep       Date:  2017-04-06       Impact factor: 4.379

Review 5.  Recent Advances in Herbal Medicines for Digestive System Malignancies.

Authors:  Jiyao Sheng; Xiaohan Zou; Ziqian Cheng; Yien Xiang; Wei Yang; Yang Lin; Ranji Cui
Journal:  Front Pharmacol       Date:  2018-11-20       Impact factor: 5.810

6.  High-Throughput Metabolomics Evaluate the Efficacy of Total Lignans From Acanthophanax Senticosus Stem Against Ovariectomized Osteoporosis Rat.

Authors:  Ai-Hua Zhang; Zhi-Ming Ma; Hui Sun; Ying Zhang; Jian-Hua Liu; Fang-Fang Wu; Xi-Jun Wang
Journal:  Front Pharmacol       Date:  2019-05-29       Impact factor: 5.810

7.  Assessing the Effectiveness of Direct Data Merging Strategy in Long-Term and Large-Scale Pharmacometabonomics.

Authors:  Xuejiao Cui; Qingxia Yang; Bo Li; Jing Tang; Xiaoyu Zhang; Shuang Li; Fengcheng Li; Jie Hu; Yan Lou; Yunqing Qiu; Weiwei Xue; Feng Zhu
Journal:  Front Pharmacol       Date:  2019-02-20       Impact factor: 5.810

Review 8.  Novel strategies for the treatment of acetaminophen hepatotoxicity.

Authors:  Jephte Y Akakpo; Anup Ramachandran; Hartmut Jaeschke
Journal:  Expert Opin Drug Metab Toxicol       Date:  2020-09-14       Impact factor: 4.481

9.  Metabolic characterization and pathway analysis of berberine protects against prostate cancer.

Authors:  Xianna Li; Aihua Zhang; Hui Sun; Zhidong Liu; Tianlei Zhang; Shi Qiu; Liang Liu; Xijun Wang
Journal:  Oncotarget       Date:  2017-04-28

10.  Authentic compound-free strategy for simultaneous determination of primary coumarins in Peucedani Radix using offline high performance liquid chromatography-nuclear magnetic resonance spectroscopy-tandem mass spectrometry.

Authors:  Yao Liu; Qingqing Song; Wenjing Liu; Peng Li; Jun Li; Yunfang Zhao; Liang Zhang; Pengfei Tu; Yitao Wang; Yuelin Song
Journal:  Acta Pharm Sin B       Date:  2018-02-21       Impact factor: 11.413

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.